The official journal of ESPT is Drug Metabolism and Personalized Therapy (DMPT).
Drug Metabolism and Personalized Therapy provides up-to-date Research Articles, Reviews and Opinion Papers in the wide field of drug metabolism research, covering established, new and potential drugs, environmentally toxic chemicals, the mechanisms by which drugs may interact with each other and with biological systems, and the pharmacological and toxicological consequences of these interactions and drug metabolism and excretion. Areas covered include: drug metabolizing enzymes, pharmacogenetics and pharmacogenomics, biochemical pharmacology, molecular pathology, clinical pharmacology, pharmacokinetics and drug interactions, immunopharmacology, and neuropsychopharmacology. DMPT also publishes Short Communications, Letters to the Editor, Case Reports, and Editorials.
We would like to invite all members of ESPT to submit their scientific work – Reviews, Research Articles, Short Communications, Case Reports, Letters to the Editor – to DMPT.
Publication of color figures is free of charge both in online and print editions.
• Ahead of print online publication for all accepted papers after peer reviewing.
• Rapid publication times: max. 3 weeks from acceptance to online publication.
• High quality manuscript processing through Thomson Reuters ScholarOne.
• Open Access option available for all accepted papers.
Please submit at http://mc.manuscriptcentral.com/dmdi.
Chemical Abstracts, Elsevier EMBASE, Elsevier BIOBASE, ISI BIOSIS Previews, ISI International Pharmaceutical Abstracts, Pro Quest Natural Sciences - Toxline, and Medline.